Brief Behavioural Activation (Brief BA) for adolescent depression: a pilot study by Pass, Laura et al.
PASS, LEJUEZ & REYNOLDS BRIEF BA FOR ADOLESCENT DEPRESSION A PILOT STUDY:  
ACCEPTED MANUSCRIPT 
1 
 
Brief Behavioural Activation (Brief BA) for adolescent depression: A pilot study  
 
Note: This article has been accepted for publication (First View) in Behavioural and 
Cognitive Psychotherapy by Cambridge University Press, and should be referenced as: 
 
Pass, L., Lejuez, C. W., & Reynolds, S. (2017).  Brief Behavioural Activation (Brief BA) for 
Adolescent Depression: A Pilot Study. Behavioural and Cognitive Psychotherapy, 1-13.  
doi:10.1017/S1352465817000443 
 
The published article can be accessed here: 
https://www.cambridge.org/core/journals/behavioural-and-cognitive-psychotherapy 
The British Association for Behavioural and Cognitive Psychotherapies owns full copyright 
in all forms and media for this publication. 
 
Abstract 
Background: Depression in adolescence is a common and serious mental health problem.  In 
the UK, access to evidence based psychological treatments is limited and training and 
employing therapists to deliver these is expensive.  Brief Behavioral Activation for the 
Treatment of Depression (BATD) has great potential for use with adolescents and to be 
delivered by a range of healthcare professionals, but there is limited empirical investigation 
with this group.   
Aims: To adapt BATD for depressed adolescents (Brief BA) and conduct a pilot study to 
assess feasibility, acceptability and clinical effectiveness.   
Methods: Twenty depressed adolescents referred to the local NHS Child and Adolescent 
Mental Health service (CAMHs) were offered 8 sessions of Brief BA followed by a review 
around one month later.  Self- and parent- reported Routine Outcome Measures (ROMs) were 
collected at every session. 
Results: Nineteen of the 20 young people fully engaged with the treatment and all reported 
finding some aspect of Brief BA helpful.  Thirteen (65%) required no further psychological 
intervention following Brief BA, and both young people and parents reported high levels of 
acceptability and satisfaction with the approach.  The pre-post effect size of Brief BA 
treatment was large.  
Conclusions:  Brief BA is a promising innovation in the treatment of adolescent depression.  
This approach requires further evaluation to establish effectiveness and cost effectiveness 
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compared with existing evidence-based treatments for adolescent depression.   Other 
questions concern the effectiveness of delivery in other settings and when delivered by a 
range of professionals.   
 
Adolescent Depression 
Depression is a serious mental health problem in adolescence, with 2.6% of the world 
youth population experiencing depression at any one time (Polanczyk, Salum, Sugaya, Caye 
and Rohde, 2015).  Core symptoms include depressed mood or irritability, and/or a loss of 
interest and pleasure (anhedonia) along with other cognitive and behavioural changes 
including appetite and sleep disturbances, cognitive difficulties and negative self-perceptions 
(American Psychological Association, 1994).  Depression in adolescence predicts a wide 
range of long-term negative impacts, including mental illness in adulthood (McLeod, 
Horwood and Fergusson, 2016), educational underachievement (Fletcher, 2008), and 
increased risk of suicidal behaviour (Cash and Bridge, 2009).  
 
Adolescent Depression Treatments 
 The current National Institute for Health and Care Excellence (NICE) guidelines for 
treatment of moderate/severe depression in young people recommend individual Cognitive-
Behavioural Therapy (CBT), Interpersonal Therapy (IPT), family therapy or psychodynamic 
psychotherapy for at least three months (NICE, 2015).  NICE recommend that such therapies 
should only be provided by healthcare professionals trained to an appropriate standard of 
competence.  However, there are a limited number of therapists with these qualifications 
which can be a barrier to accessing these treatments.  Waiting times in CAMH services across 
the UK are extremely variable (National Society for the Prevention of Cruelty to Children, 
2015), can be lengthy (House of Commons Health Committee, 2014) and GPs report 
inadequate CAMH provision for the young people they try to refer (Stem4, 2016).  Evidence-
based treatments are simply not able to meet the needs of the majority of depressed young 
people 
 There are also difficulties engaging depressed adolescents in psychological therapy.  
Recent trials have evidenced a significant level of drop out from CBT and other therapies 
(Goodyer et al., 2016), and a meta-analysis of adolescent depression treatments found 
psychological interventions with a cognitive component were no more effective than those 
without cognitive work (Weisz, McCarty and Valeri, 2006).   
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Behavioural Activation for Depression 
In the UK Behavioural Activation (BA) is recommended as an evidence-based 
treatment for adult depression (NICE, 2016).  BA is based on the behavioural theory of 
depression and aims to improve mood by increasing positive reinforcement for healthy 
behaviours.  Meta-analyses suggest that BA is equivalent to CBT for adults with depression 
(Cuijpers, van Straten, Andersson and van Oppen, 2008; Ekers, Richards and Gilbody, 2008) 
and can be more effective than medication (Ekers et al., 2014).   Two contemporary BA 
approaches have been developed.  One involves 16-20 sessions (BA; Martell, Addis and 
Jacobson, 2001; Martell, Dimidjian and Hermann-Dunn, 2010) and the other is a brief, more 
structured approach (Behavioral Activation Treatment for Depression, BATD: Lejuez, Hopko 
and Hopko, 2001; Lejuez, Hopko, Acierno, Daughters and Pagoto, 2011).   
Treatment complexity/length and clinician level of training do not affect BA 
treatment outcome (Ekers et al., 2008).  Because BA can be delivered by staff who are not 
formally trained as psychological therapists, it is more cost effective than CBT (Richards et 
al., 2016). 
 
Brief BA for Adolescent Depression 
 Almost no work has applied BA to adolescents, despite many aspects of BA fitting 
well with the characteristics of this developmental period (e.g. lower cognitive demands, 
ability to individualise therapy within a straightforward approach). Ruggiero, Morris, Hopko 
and Lejuez (2005) reported a case study of using BATD successfully with a depressed 
adolescent, with an indication that depression symptoms reduced as reinforcing life events 
increased.  One small RCT (N = 60) has evaluated Martell-based, 14 session BA with 
depressed adolescents in the USA (McCauley et al., 2015).  Adolescents were randomised to 
either BA or evidence-based practice for depression, and both groups showed significant 
improvements in depression symptoms and functioning (with no difference between groups). 
To create a more streamlined BA intervention, Pass and Reynolds (2014) adapted 
BATD for use in routine CAMHs settings in the UK (see Pass, Brisco and Reynolds, 2015).  
The aim was to create a brief, structured behavioural intervention that was acceptable to 
young people and could be delivered by a range of professionals, in order to increase 
treatment accessibility.  Treatment takes 6-8 sessions, involves parents and is delivered using 
a structured session by session workbook (Pass & Reynolds, 2014) and therapist guide (Pass, 
Brisco, Hodgson, & Reynolds,2015).  It can be used in cases where there is self-harm/suicidal 
ideation (Pass, Whitney and Reynolds, 2016) and can be delivered successfully by non-
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specialist clinicians (Pass, Hodgson, Whitney and Reynolds, in press).   This study reports the 
outcomes from a pilot and feasibility study of Brief BA in NHS CAMHs with data from 20 
consecutive cases referred for treatment.  
 
Method 
Procedure 
The study was completed within a local CAMHs Anxiety and Depression pathway.  
Potential participants were identified by NHS clinicians if they wished to receive treatment 
for depression.  Brief BA was offered when a BA therapist and supervision was available.  
Clinicians outlined the usual treatment options (typically CBT, sometimes with SSRI 
medication if indicated) and described Brief BA to young people and parents.  Collaborative 
decision-making determined treatment choice.   
[Local NHS Trust name removed for blind review] NHS Foundation Trust provided 
approval for an audit of these cases and dissemination of the findings (ref: 2623).  All data 
obtained from young people and parents were part of service routine data collection.  
 
Participants 
Participants were the first 20 young people who opted to receive Brief BA treatment, 
referred between February 2014 and August 2015.  Strict inclusion/exclusion criteria were 
not used; referrals were received from clinicians within the service for young people with 
depressive symptoms causing significant impairment in functioning. Therefore this case 
series was uncontrolled and unblinded, with no comparison group. 
 
Measures 
Revised Child Anxiety and Depression Scale: Child and Parent versions 
(RCADS, RCADS-P; Chorpita, Yim, Moffitt, Umemoto and Francis, 2000).  The 
RCADS and RCADS-P are 47-item questionnaires assessing anxiety and low mood in 8 – 18 
year olds.  Both have good psychometric properties (e.g. Chorpita et al., 2000; Chorpita, 
Moffitt and Gray, 2005; Ebesutani, Bernstein, Nakamura, Chorpita and Weisz, 2010), and 
provide age and gender normed t-scores with clinical cut offs (t scores of 0-64= normal 
range, 65-69= borderline clinical range, 70+= clinical range).  The full RCADS and RCADS-
P were completed at assessment and final treatment session.  The self and parent report 
Depression subscales were completed at the start of every BA session and was the primary 
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outcome measure.  An additional question (‘I thought about killing myself’/’My child 
thought about killing themselves’) was added to monitor risk.    
 
Outcome Rating Scale (ORS; Miller and Duncan, 2000).  The ORS is a measure of 
functioning in four areas: Individual, Interpersonal, Social and Overall.  These are marked on 
four 10cm visual analog scales which are summed to give a total score, with higher scores 
indicating higher functioning.  Young people and their parent were asked to rate the ORS 
every session.  The ORS has good concurrent validity with other treatment outcome measures 
and high internal consistency and test retest reliability (Duncan, Sparks, Miller, Bohanske 
and Claud, 2006).  
 
Session Rating Scale (SRS; Duncan et al., 2003).  The SRS is an ultra-brief measure 
of therapeutic alliance.  Similar to the ORS, the SRS scores are marked on four 10cm visual 
analog scales which are summed to give a total score across four areas: Relationship, Goals 
and Topics, Approach or Method, and Overall Alliance.  A higher score indicates a higher 
client rating of therapeutic alliance.  The SRS has good psychometrics, including moderate 
concurrent validity with longer self-report measures of alliance (Duncan et al., 2003).  The 
SRS was completed after each session by the young person.   
 
Brief BA feedback questionnaire.  At the end of treatment young people and parents 
were asked to complete a questionnaire about their experiences of Brief BA.  There were 
three forced choice questions about whether they liked the approach (‘really liked it to ‘hated 
it’), whether they found BA useful (‘very’ to ‘not at all’), and whether they would 
recommend BA to a friend/for a friend’s child (‘yes definitely’ to ‘definitely not’).  Young 
people and parents were also asked open ended questions about what they liked best about 
BA, what they liked least, and any other comments including about the practical resources. 
 
Participant Characteristics 
Most participants were white, 16 year old females, representative of all young people 
who were referred with depression during this period (Orchard et al., 2016).  Ten had at least 
one comorbid anxiety disorder (see Table 1), and in addition one had a diagnosis of Chronic 
Fatigue Syndrome (CFS) and another was waiting for an Autism Spectrum Disorder (ASD) 
assessment.  There were no comorbid behavioural diagnoses. 
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 Nine young people were taking prescribed SSRI medication, and two of these had 
changes in medication type/dose during Brief BA treatment following Psychiatry reviews.  
Thirteen young people reported active suicidal ideation assessment, indicating an active plan 
to end their life.  
Four participants had previously received CBT (two for anxiety and two for 
depression).  A higher proportion had accessed some form of counselling, but this varied 
greatly and clinical records were not available to accurately assess this. 
 
Table 1: Participant characteristics 
Characteristic Total (%) 
Gender (% female) 18 (90%) 
Mean age in years (SD) 16.12 (0.71) 
Age range (years) 14 - 17 
Ethnicity  
- Caucasian 18 (90%) 
- Other 2 (10%) 
Active suicidal ideation 13 (65%) 
Anti-depressant medication 9 (45%) 
Previous psychological therapy 4 (20%) 
Comorbidity  
- None 10 (50%) 
- One anxiety disorder 7 (35%) 
- Two anxiety disorders 2 (10%) 
- 3+ anxiety disorders 1 (5%) 
Family involvement in Brief BA  
- None 1 (5%) 
- Minimal 1 (5%) 
- Routine 18 (90%) 
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Brief BA Treatment 
Brief BA involves 6-8 one-hour individual sessions with structured parental 
involvement in part of sessions 1, 6 and 8.  There is a review session with young person and 
parent approximately one month after the final treatment session (see Table 2 for Brief BA 
overview).  One young person did not have any parental involvement as she was attending 
boarding school, and another attended most sessions alone and parental involvement was 
minimal. 
 
Table 2: Brief BA for adolescent depression: Session overview  
Session  Young person content  Parent content Homework 
1 Introduction to Brief BA approach 
and rationale, session workbook. 
Attend part of session 
(rationale, structure of Brief 
BA), parent workbook. 
Activity 
log 
2 Review of Brief BA approach, 
review of activity log, session 
workbook. 
Parent workbook Activity 
log 
3 Review of activity log, introduction 
to values, session workbook. 
Parent workbook Activity 
log, Values 
4-5 Review of values, plan valued 
activities across life areas, session 
workbook. 
Parent workbook Valued 
activities 
6 Review of progress, introduction to 
problem-solving and contracting, 
session workbook. 
Attend part of session 
(review, problem-solving, 
contracts), parent workbook. 
Valued 
activities 
7 Review of progress, identification 
of activities to continue working 
towards, session workbook. 
Parent workbook Valued 
activities 
8 Review of progress, relapse 
prevention, session workbook, 
relapse prevention handout. 
Attend part of session 
(review, relapse prevention), 
parent workbook. 
 
Review Review of progress, plan for further 
input/discharge. 
Attend part of review 
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Brief BA Clinicians and Supervision 
Brief BA was delivered in the routine CAMHs setting by three therapists including a 
clinical psychologist (n = 12) and two graduate psychologists, both of whom received 
additional training in Brief BA (4 cases each).  For further details on Brief BA training for 
clinicians, see Pass et al. (under review).  Supervision was provided by a clinical psychologist 
involved in the adaptations for Brief BA.  During Brief BA other multidisciplinary clinical 
care was provided as appropriate (e.g. ongoing Psychiatry reviews).   
 
Treatment Adherence 
No treatment adherence measure is available for Brief BA.  However, all clinicians 
sought consent for audio recording of sessions, and a random selection of tapes were listened 
to by one of the developers of Brief BA (LP).  BA supervision was held fortnightly (weekly 
for the first training case for each clinician) and used treatment audio recordings.   
 
Analysis plan 
Data were explored to assess the assumptions of parametric testing (paired t-tests).  Where 
variables violated these assumptions, a non-parametric equivalent test was used (Wilcoxon 
signed ranks test) and any change to the results reported, for all analyses a p <.05 significance 
level was used. We used an ‘Intent to treat’ (ITT) analysis; all participants were included in 
the analysis.  Where data were missing, a last observation carried forward (LOCF) procedure 
was used.  The exception to this was when no data was available at any time point.  For data 
missing from assessment, a first observation carried backwards (FOCB) procedure was used.   
 
Results 
Engagement  
Out of the 20 adolescents who started Brief BA, 19 engaged with the treatment and 18 
completed all eight sessions and review.  One young person reported that Brief BA was not the 
right treatment for her after four sessions.  Two more sessions were used to review her 
symptoms and progress, before discontinuing Brief BA and putting her onto the waiting list for 
CBT.  She subsequently declined CBT or any other input and was discharged from the service.  
Another young person attended four sessions of Brief BA then was discharged because her 
symptoms remitted.  
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Primary Outcome: RCADS Depression Subscale 
Pre- and post-treatment data for the RCADS Depression subscale are presented in 
Table 3.  The data were slightly non-normally distributed, so pre/post comparisons were run 
both with parametric and non-parametric tests.  There was no difference in results, so 
parametric tests are reported for simplicity along with bias corrected and accelerated (BCa) 
bootstrapped 95% confidence intervals.  
 
Table 3: Pre- and post- Brief BA RCADS Depression subscale raw scores 
Respondent and time 
point 
N Mean raw 
score (SD) 
Raw score 
range 
Median 
raw score 
Interquartile 
range 
Self-report RCADS-Dep    
Baseline assessment  20 20.65 (5.66) 8 – 28  21 17 – 25.75 
Session 8  20 15.00 (6.79) 5 – 30 14 9.5 – 19.5  
Review  20 14.45 (7.98) 2 – 30 12.5 8.75 – 20.75  
Parent-report RCADS-Dep     
Baseline assessment  19 16.58 (5.85)                  8 –29 16 12 – 22  
Session 8  19 11.63 (3.95) 5 – 21 11 8 – 14  
Review  19 10.66 (6.52) 1 – 29 10 6 – 14 
 
 As shown in Table 4, there was a significant reduction in self-reported depression 
symptoms from assessment to session 8, and from assessment to review. This reduction was 
also shown by mean t-scores moving from the clinical range at assessment (M = 82.25, SD = 
15.95), to the borderline range at session 8 (M = 66.25, SD = 16.19) and review (M = 65.40, 
SD = 19.91).   This decrease equates to a large effect size (0.2 = small, 0.5 = medium, 0.8 or 
above = large effect size; Cohen, 1992). 
 
Table 4: Pre and post comparisons of RCADS-Depression raw scores  
Respondent and comparison 
time points 
N df T-value BCa bootstrapped 
95% CI 
Cohen’s d 
Self-report RCADS-Dep 
Assessment – Session 8  20 19 3.97** [2.50 – 8.83] 0.90 
Assessment –  Review 20 19 4.30** [3.20 – 9.55] 0.90 
Parent report RCADS-Dep 
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Assessment – Session 8 19 18 5.50** [3.26– 6.68]  0.99 
Assessment – Review 19 18 4.10** [3.27 – 8.90] 0.96 
* = < .05, ** = p < .01 
 
Parent-report RCADS Depression Subscale 
The pre- and post-treatment mean scores for the parent-reported RCADS Depression 
subscale are shown in Table 3, and the pre and post comparisons in Table 4.  There was a 
significant reduction in parent-reported RCADS Depression scores from assessment to 
session 8, and from assessment to review. The parental mean t-scores reduced but stayed in 
the clinical range across time points (assessment M = 86.53, SD = 18.21; session 8 M = 
72.00, SD = 11.92; review M = 69.24, SD = 19.59). In line with self-report scores, the parent-
reported reduction in depression symptoms equates to a large effect size (Cohen, 1992). 
 
Secondary Analyses: Outcome Rating Scale 
The ORS was completed for the first time at the beginning of session 1 as it was not 
part of the assessment measures.  The pre- and post-treatment mean ORS scores are presented 
in Table 5.  There was a significant increase in self-reported functioning from session 1 to 
session 8 (t(17) = -2.51, p = .022, d = 0.73), and from session 1 to review (t(17) = -2.44, p = 
.026, d = 0.73).  Parental report also indicated a significant increase in functioning from 
session 1 to session 8 (t(15) = -5.60, p < .001, d = 1.47) and from session 1 to review (t(15) = 
-4.69, p < .001, d = 1.12). The treatment effect size was medium for self-report, and large for 
parent-report (Cohen, 1992).    
 
Table 5: Pre and Post-Brief BA ORS scores 
Respondent and 
time point 
N Mean score 
(SD) 
Range Median Interquartile 
range 
Self-report ORS 
Session 1  18 18.21 (9.33) 1.10 – 36.95  16.05  12.88 – 25.10  
Session 8  18 25.30 (10.16) 8.00 – 38.30  27.45  17.63 – 33.38  
Review  18 25.69 (11.23) 4.90 – 39.10  29.55 15.83 – 35.31  
Parent report ORS 
Session 1  16 17.73 (8.67) 4.40 – 31.20  18.55  11.85 – 26.33  
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Session 8  16 30.04 (8.11) 8.80 – 38.50  32.60  25.38 – 35.65  
Review  16 28.21 (10.06) 3.10 – 39.90  28.05 21.03 – 36.88  
Note: Case 7 excluded as she did not feel her ORS self-report was valid, so this measure was 
discontinued; Case 17 excluded as both self and parent-report ORS score were 0 at session 1, 
indicating a lack of validity; Case 9 had no parent ORS data; Case 15 excluded as parent 
ORS only available from session 6. 
 
Clinical outcomes  
In addition to scores on routine outcome measures we examined clinical outcomes for 
each young person.  Following completion of Brief BA, 13 young people (65%) required no 
further psychological input; of this group eight were discharged from the service completely 
and five remained on SSRI medication (so required on-going psychiatric monitoring).  Of the 
remaining seven young people, four were referred for CBT (three for anxiety, one for anxiety 
and low mood). Two young people were offered additional input in CAMHs but declined this 
(one who had disengaged with Brief BA, and one who was offered both group CBT for 
anxiety and family therapy).  One young person was referred to adult mental health services 
for CBT for anxiety as she was almost 18.  
 
Reliable and Clinically Significant Change: RCADS Depression subscale 
Reliable change on the RCADS depression subscale was indicated by a change score 
greater than the published Reliable Change Criterion (RCC) based on each individual’s age 
and gender.  Clinically significant change was defined as moving down a clinical category.  
Two young people were already in the normal range on the RCADS Depression subscale at 
assessment, therefore clinically significant change was not possible.  Out of the remaining 18, 
six (33%) showed reliable and clinically significant change between assessment and session 
8. Two showed reliable improvement but did not change clinical category, while the others 
did not show reliable change in their scores. Between assessment and BA review session, 
seven (39%) of the 18 young people who could evidence reliable and clinically significant 
change showed this.  Three others also showed reliable improvement but did not change 
clinical category.  
 
Reliable and Clinically Significant Change: ORS 
Four young people scored in the normal range (28+) on the ORS at assessment so 
clinically significant change was not possible.  Six (38%) of the 16 young people able to 
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evidence reliable and clinically significant change (increase of more than 5 points and move 
from clinical to normal range) showed this between assessment at BA session 8.  Another 
four showed reliable improvement but their ORS scores remained in the clinical range.  
Between assessment and BA review, eight (50%) of the 16 young people who could 
show reliable and clinically significant change evidenced this. Another young person showed 
reliable improvement but remained in the clinical range. 
 
Treatment Satisfaction 
Therapeutic alliance ratings were high across all Brief BA sessions, with mean SRS 
scores ranging from 35.55 (session 1) to 38.09 (session 7).  At the end of treatment, feedback 
was received from 17 young people and 16 parents. The majority (over 70%) reported that 
they liked or really liked Brief BA, and importantly, nobody said they disliked it.  Nearly all 
(94%) of young people reported they would definitely or probably recommend Brief BA to a 
friend, and 88% found the approach useful.  Open ended comments were also positive, 
including on the therapeutic relationship (e.g. ‘they truly listened to me’, ‘being able to talk 
freely’) and often directly about the Brief BA content (e.g. ‘It made me think about my 
activities and how they affect my mood’, ‘I like that it made me think about my own values’). 
Over 75% of parents liked or really liked Brief BA, 81% found it very or fairly useful, 
and over 87% would recommend the treatment to a friend for their child.  Positive parental 
comments identified the practical elements of Brief BA (e.g. ‘the focus on positive outcomes 
and encouraging activities, and a balance of fun and social as well as achievement’) and the 
importance of the therapeutic relationship (e.g. ‘the therapist treated [young person] like a 
young adult’). 
When asked what they liked least about Brief BA, four young people chose not to 
write anything and one young person stated ‘nothing, I liked it all’.  The others 
identifiedvarious minor issues, including challenges with completing activity logs and 
engaging in the work between sessions (e.g. ‘the activity logs at the start’, ‘having to organise 
things’).  Five parents did not identify any negative aspect of Brief BA.  A few identified 
concerns over the brief nature of the intervention (e.g. ‘8 weeks was probably too short, I feel 
she needs a little more help’), or practical issues (e.g. ‘planning appointments’).  Two parents 
commented that they should have had greater involvement in the treatment (e.g. ‘I sometimes 
felt that my concerns about my child were not considered’, ‘the lack of communication 
between therapist, child and parent- a debrief I felt was needed to end the session’).  
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Discussion 
The aim of this pilot study was to investigate the acceptability, feasibility and clinical 
effectiveness of a brief, structured behavioural intervention adapted for adolescents within a 
routine CAMHs setting.  The high treatment completion rate, SRS ratings and feedback 
scores suggest Brief BA was acceptable to both young people and their parents.  Brief BA 
resulted in a significant decrease in depression symptoms over the course of treatment and a 
significant increase in functioning on both self and parent report.  The treatment effect size on 
depression symptoms was large, and the majority of young people (65%) needed no further 
psychological intervention following Brief BA. These findings are promising (particularly 
given this was a routine CAMHs population with a range of co-morbidity, suicidal ideation 
and previous therapy experience), and suggest that Brief BA warrants further evaluation on a 
larger scale.   
Developing alternative treatments for adolescent depression is important and urgent.  
Adolescent depression is a serious health problem, a cause of great distress and long-term 
impairments in functioning and a leading cause of premature death (Thapar, Collishaw, Pine, 
& Thapar, 2012).  A number of evidence-based psychological therapies are recommended but 
they have some serous limitations.  First, and perhaps most importantly, many young people 
do not engage with treatment and drop out before they receive the planned number of 
sessions.   Secondly, existing psychological treatments (e.g. CBT, IPT, family therapy) are 
complex, require lengthy training and are delivered by specialist psychological therapists.  
This means that access to treatment is extremely limited and most young people with 
depression (or other mental health problems) are not able to access treatment at all or must 
endure lengthy waiting lists.   Evidence-based treatments therefore are simply not able to 
meet the needs of the majority of depressed young people.  
Brief Behavioural Activation has the potential to overcome these two key limitations 
of existing therapies, engagement and accessibility.  Brief BA treatment appears to engage 
young people successfully in treatment - although this must be examined in a larger sample 
and in other clinical settings.  Features of Brief BA that may appeal more to young people 
include it being short-term, focused and simple to understand.  Brief BA builds on a strong 
theoretical base (learning theory) that can explain symptoms of depression in simple (as well 
as more complex) terms.  This simple version of the model can be adapted to the individual 
young person and their experience, and leads directly to a treatment plan.  Successful 
engagement in any treatment is extremely important because it means that depressed young 
people are more likely to receive a full ‘dose’ of treatment and end therapy through mutual 
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agreement with their therapist.  If further treatment (medication or a more intensive 
psychological therapy) is then required, this engagement means that care can be more 
continuous and coherent and the well-being of the young person can be monitored.   
BA also has the potential to be more accessible to young people.  This is because the 
simple model of depression and treatment plan can be delivered to patients in a flexible but 
highly structured format.  The treatment has been designed so that it could be delivered 
skilfully, and with fidelity, by professionals who are not fully trained psychotherapists.  If 
effective interventions can be delivered by a wider range of professionals, in community 
settings (e.g. schools) there is potential to provide this brief focused and simple therapy to 
young people more promptly and efficiently.   
However, this pilot study can only provide data that supports further research and 
evaluation of Brief BA.  The treatment was provided in just one clinical setting by members 
of a team responsible for adapting Brief BA for depressed adolescents.  The intervention 
clearly needs to be evaluated in more independent clinical settings to assess if these 
promising data can be replicated in services not directly affiliated with the research team, and 
in different types of services and staff teamsIn addition, the absence of a control or active 
comparison treatment group means we cannot compare outcomes of Brief BA with current 
evidence-based treatments.  Recent reviews (Weisz et al., 2006) and treatment trials 
(Goodyer et al., 2017) suggest that a range of psychological therapies for depression are 
equivalent.  It is possible that Brief BA is not more effective than other psychological 
therapies; however, it may be more cost effective,  and even more importantly, more 
acceptable to young people who are depressed.  
These are promising preliminary results that need to be investigated further.  
However, Brief BA could be one possible solution to considerably stretched CAMH services 
delivering effective, cost effective, and engaging therapies to adolescents with depression. 
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